Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, the FDA issued a warning letter to Sharp Drugs, Inc., operating as Island Drug and Surgical, on August 2, 2019, regarding drug products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office and violation count are not documented in this metadata. To understand the specific compliance issues and required corrective actions, the complete warning letter would need to be reviewed.